David Nelson

6.6k total citations
145 papers, 5.2k citations indexed

About

David Nelson is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David Nelson has authored 145 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 34 papers in Immunology and 27 papers in Cellular and Molecular Neuroscience. Recurrent topics in David Nelson's work include Neuroscience and Neuropharmacology Research (25 papers), Mitochondrial Function and Pathology (14 papers) and Cancer, Hypoxia, and Metabolism (14 papers). David Nelson is often cited by papers focused on Neuroscience and Neuropharmacology Research (25 papers), Mitochondrial Function and Pathology (14 papers) and Cancer, Hypoxia, and Metabolism (14 papers). David Nelson collaborates with scholars based in United States, Australia and United Kingdom. David Nelson's co-authors include Maria Erecińska, Marc Yudkoff, Jerry D. Glickson, Yevgeny Daikhin, Ian A. Silver, Elizabeth Sztul, David F. Wilson, Kavindra Nath, Dennis B. Leeper and Itzhak Nissim and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David Nelson

140 papers receiving 5.0k citations

Peers

Countries citing papers authored by David Nelson

Since Specialization

Citations

This map shows the geographic impact of David Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nelson more than expected).

Fields of papers citing papers by David Nelson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nelson. The network helps show where David Nelson may publish in the future.

Co-authorship network of co-authors of David Nelson

This figure shows the co-authorship network connecting the top 25 collaborators of David Nelson. A scholar is included among the top collaborators of David Nelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Nelson. David Nelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lonidamine Induced Selective Acidification and De-Energization of Prostate Cancer Xenografts: Enhanced Tumor Response to Radiation Therapy 2024 ·Cancers ·(unknown), Pradeep Kumar Gupta, (unknown), Fernando Arias‐Mendoza, David Nelson, Cameron J. Koch, Vivek Narayan, Mary Putt, Kavindra Nath	4
2	Metabolic Imaging Biomarkers of Response to Signaling Inhibition Therapy in Melanoma 2024 ·Cancers ·Pradeep Kumar Gupta, (unknown), Fernando Arias‐Mendoza, David Nelson, (unknown), Stephen Pickup, Jerry D. Glickson, Kavindra Nath	1
3	1H and 31P Magnetic Resonance Spectroscopic Metabolomic Imaging: Assessing Mitogen-Activated Protein Kinase Inhibition in Melanoma 2024 ·Cells ·Pradeep Kumar Gupta, (unknown), Fernando Arias‐Mendoza, David Nelson, Kavindra Nath	0
4	pH-dependent structural characteristics of lonidamine: ¹ H and ¹³ C NMR study 2023 ·RSC Advances ·Pradeep Kumar Gupta, (unknown), (unknown), Stephen Pickup, David Nelson, Jerry D. Glickson, Kavindra Nath	0
5	Effect of Lonidamine on Systemic Therapy of DB-1 Human Melanoma Xenografts with Temozolomide 2017 ·Anticancer Research ·Kavindra Nath, David Nelson, (unknown), Mary Putt, Seung‐Cheol Lee, Dennis B. Leeper, Jerry D. Glickson	12
6	CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice 2016 ·PLoS ONE ·Xuguang Chen, Yunyue Wang, David Nelson, (unknown), (unknown), Bhumi Patel, Ilaria Conti, Juan C. Jaén, Barrett J. Rollins	44
7	Mechanism of antineoplastic activity of lonidamine 2016 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Kavindra Nath, Lili Guo, (unknown), David Nelson, Alexander A. Shestov, Seung‐Cheol Lee, (unknown), Rong Zhou, Dennis B. Leeper, Andrew P. Halestrap, Ian A. Blair, Jerry D. Glickson	167
8	Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice 2016 ·PLoS ONE ·Kavindra Nath, David Nelson, Mary Putt, Dennis B. Leeper, Bradley Garman, Katherine L. Nathanson, Jerry D. Glickson	10
9	Effects of temperature on intracellular sodium, pH and cellular energy status in RIF‐1 tumor cells 2004 ·NMR in Biomedicine ·Andriy M. Babsky, S. K. Hekmatyar, Suzanne Wehrli, David Nelson, Navin Bansal	7
10	Prediction of Treatment Response of Head and Neck Cancers with P-31 MR Spectroscopy from Pretreatment Relative Phosphomonoester Levels 2002 ·Academic Radiology ·Amita Shukla‐Dave, Harish Poptani, Laurie A. Loevner, Anthony Mancuso, Haçène Serrai, David I. Rosenthal, (unknown), David Nelson, Kristen L. Zakian, Fernando Arias‐Mendoza, Mark Rijpkema, Jason A. Koutcher, Truman R. Brown, Arend Heerschap, Jerry D. Glickson	33
11	Methylmalonate toxicity in primary neuronal cultures 1998 ·Neuroscience ·BethAnn McLaughlin, David Nelson, Ian A. Silver, Maria Erecińska, M.‐F. Chesselet	96
12	Metabolic and energetic properties of isolated nerve ending particles (synaptosomes) 1996 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·(unknown), David Nelson, Ian A. Silver	40
13	Cerebral Aspartate Utilization: Near‐Equilibrium Relationships in Aspartate Aminotransferase Reaction 1993 ·Journal of Neurochemistry ·Maria Erecińska, David Pleasure, David Nelson, Itzhak Nissim, Marc Yudkoff	29
14	Energy metabolism in islets of Langerhans 1992 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Maria Erecińska, Jadwiga Bryła, (unknown), Martin D. Meglasson, David Nelson	99
15	Glutamate Dehydrogenase Reaction as a Source of Glutamic Acid in Synaptosomes 1991 ·Journal of Neurochemistry ·Marc Yudkoff, Itzhak Nissim, David Nelson, Zhi‐Ping Lin, Maria Erecińska	44
16	Bioenergetic response of pancreatic islets to stimulation by fuel molecules 1989 ·Metabolism ·Martin D. Meglasson, June Nelson, David Nelson, Maria Erecińska	40
17	Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: Immunosuppression, immunogenicity, and relation to immunosuppressive tumor products 1989 ·Cancer Immunology Immunotherapy ·Margaret Nelson, David Nelson, George J. Cianciolo, Ralph Snyderman	36
18	Glucose and Synaptosomal Glutamate Metabolism: Studies with [¹⁵N]Glutamate 1988 ·Journal of Neurochemistry ·Maria Erecińska, Małgorzata Załęska, Itzhak Nissim, David Nelson, F. Dagani, Marc Yudkoff	77
19	Brugia pahangi: serum-dependent cell-mediated reactions to sheathed and exsheathed microfilariae. 1984 ·PubMed Central ·Ramaswamy Chandrashekar, U. R. Rao, D. Subrahmanyam, K Hopper, David Nelson, Margaret W. King	10
20	Autoantibodies in cancer patients 1977 ·Pathology ·David Nelson	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact